Invesco’s Mirum Pharmaceuticals MIRM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.29M | Sell |
64,653
-248,770
| -79% | -$12.7M | ﹤0.01% | 2383 |
|
|
2025
Q1 | $14.1M | Buy |
313,423
+14,144
| +5% | +$637K | ﹤0.01% | 1600 |
|
|
2024
Q4 | $12.4M | Buy |
299,279
+14,747
| +5% | +$610K | ﹤0.01% | 1720 |
|
|
2024
Q3 | $11.1M | Buy |
284,532
+487
| +0.2% | +$19K | ﹤0.01% | 1782 |
|
|
2024
Q2 | $9.71M | Buy |
284,045
+245,024
| +628% | +$8.38M | ﹤0.01% | 1804 |
|
|
2024
Q1 | $980K | Sell |
39,021
-45,846
| -54% | -$1.15M | ﹤0.01% | 2989 |
|
|
2023
Q4 | $2.51M | Sell |
84,867
-78,900
| -48% | -$2.33M | ﹤0.01% | 2529 |
|
|
2023
Q3 | $5.18M | Buy |
163,767
+128,374
| +363% | +$4.06M | ﹤0.01% | 2185 |
|
|
2023
Q2 | $916K | Sell |
35,393
-5,183
| -13% | -$134K | ﹤0.01% | 2932 |
|
|
2023
Q1 | $975K | Sell |
40,576
-370
| -0.9% | -$8.89K | ﹤0.01% | 2902 |
|
|
2022
Q4 | $798K | Buy |
40,946
+8,465
| +26% | +$165K | ﹤0.01% | 3017 |
|
|
2022
Q3 | $682K | Sell |
32,481
-221
| -0.7% | -$4.64K | ﹤0.01% | 3061 |
|
|
2022
Q2 | $636K | Buy |
32,702
+2,011
| +7% | +$39.1K | ﹤0.01% | 3195 |
|
|
2022
Q1 | $675K | Sell |
30,691
-17,066
| -36% | -$375K | ﹤0.01% | 3225 |
|
|
2021
Q4 | $762K | Buy |
47,757
+8,319
| +21% | +$133K | ﹤0.01% | 3171 |
|
|
2021
Q3 | $786K | Sell |
39,438
-7,890
| -17% | -$157K | ﹤0.01% | 3191 |
|
|
2021
Q2 | $818K | Buy |
47,328
+1,858
| +4% | +$32.1K | ﹤0.01% | 3188 |
|
|
2021
Q1 | $901K | Buy |
45,470
+505
| +1% | +$10K | ﹤0.01% | 3072 |
|
|
2020
Q4 | $785K | Buy |
44,965
+9,143
| +26% | +$160K | ﹤0.01% | 3028 |
|
|
2020
Q3 | $691K | Buy |
+35,822
| New | +$691K | ﹤0.01% | 2970 |
|